Flagship Biosciences Applauded By Frost & Sullivan For Changing Biomarker Analysis To Find Biomarkers That Aid Drug Development And Diagnostics
February 16, 2023
February 16, 2023
SAN ANTONIO, Texas, Feb. 16 (TNSres) -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
* * *
Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses.
* * *
Fro . . .
* * *
Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses.
* * *
Fro . . .